Shopping Cart 0
Cart Subtotal

Sothema (SOT) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies


Sothema (SOT)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.


Sothema manufactures and commercializes a wide range of medicines. The company's product offerings include antibodies, antifungals, antimalarials, antiparasitics, antihelicobacter, gastrointestinal drugs, antiseptic drugs, cardiovascular drugs, antithrombotics, antidepressants, neuroleptics, neurologic system drugs, antidiabetics, corticoids, antalgics and antipyretics, among others. The company provides products in various formulations, including tablets, capsules, pouches, suspensions, creams and pomades, powders and injectable suspensions, auto-injectable syringes and other forms. Sothema also imports and distributes dental and biotechnology drugs to its customers across Morocco, Sub-Saharan Africa, Maghreb, West Africa, Persian Gulf and Europe. Sothema is headquartered in Casablanca, Morocco.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Table Of Content


Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

Sothema-Key Facts 5

Sothema-Key Employees 6

Sothema-Major Products and Services 7

Sothema-History 8

Sothema-Company Statement 9

Sothema-Locations And Subsidiaries 10

Head Office 10

Other Locations & Subsidiaries 10

Section 2-Company Analysis 11

Company Overview 11

Sothema-Business Description 12

Sothema-Corporate Strategy 13

Sothema-SWOT Analysis 14

SWOT Analysis-Overview 14

Sothema-Strengths 14

Sothema-Weaknesses 15

Sothema-Opportunities 16

Sothema-Threats 17

Sothema-Key Competitors 18

Section 3-Company Financial Ratios 19

Financial Ratios-Capital Market Ratios 19

Financial Ratios-Annual Ratios 20

Performance Chart 23

Financial Performance 23

Financial Ratios-Interim Ratios 24

Financial Ratios-Ratio Charts 25

Section 4-Company's Lifesciences Financial Deals and Alliances 26

Sothema, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 26

Sothema, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 27

Sothema, Recent Deals Summary 28

Section 5-Appendix 29

Methodology 29

Ratio Definitions 29

About GlobalData 33

Contact Us 33

Disclaimer 33

List Of Figure

List of Figures

Sothema, Performance Chart (2013-2017) 23

Sothema, Ratio Charts 25

Sothema, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 26

Sothema, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 27

List Of Table

List of Tables

Sothema, Key Facts 5

Sothema, Key Employees 6

Sothema, Major Products and Services 7

Sothema, History 8

Sothema, Subsidiaries 10

Sothema, Key Competitors 18

Sothema, Ratios based on current share price 19

Sothema, Annual Ratios 20

Sothema, Annual Ratios (Cont...1) 21

Sothema, Annual Ratios (Cont...2) 22

Sothema, Interim Ratios 24

Sothema, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 26

Sothema, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 27

Sothema, Recent Deals Summary 28

Currency Codes 29

Capital Market Ratios 29

Equity Ratios 30

Profitability Ratios 30

Cost Ratios 31

Liquidity Ratios 31

Leverage Ratios 32

Efficiency Ratios 32

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to

Products and Companies


Sothema, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Promopharm SA

Nutritional Holdings Ltd

Global Napi Pharmaceuticals

GlaxoSmithKline SAE

Amoun Pharmaceutical Company SAE

Al Hayat Pharmaceuticals